ANNX Annexon Inc. - Annexon to Present Phase 2 Archer Baseline Characteristics Associated with Confirmed Best Corrected Visual Acuity 15-Let
ANNX Annexon Inc. - Annexon to Present Phase 2 Archer Baseline Characteristics Associated with Confirmed Best Corrected Visual Acuity 15-Letter Loss in Patients with Geographic Atrophy at ASRS 2026
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.